Stéphane Piat Presents Carmat at LSI USA ‘23

CARMAT develops and commercializes Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure.
Speakers
Stéphane Piat
Stéphane Piat
CEO, Carmat